As part of $800M investment, Pfizer opens gene therapy facility in NC for early-stage production

Pfizer is betting big on gene therapy development and manufacturing. And to that end, it is centralizing its operations in—where else—North Carolina.

These days in the biopharma industry, it seems every other new facility or upgraded site is in the Tar Heel State.